Big data in drug design
نویسندگان
چکیده
منابع مشابه
Perspectives of Big Data Quality in Smart Service Ecosystems (Quality of Design and Quality of Conformance)
Despite the increasing importance of data and information quality, current research related to Big Data quality is still limited. It is particularly unknown how to apply previous data quality models to Big Data. In this paper we review Big Data quality research from several perspectives and apply a known quality model with its elements of conformance to specification and design in the context o...
متن کاملDesign Challenges in Big Data Systems
Graph pattern matching is a fundamental operation for many applications, and it is exhaustively studied in its classical forms. Nevertheless, there are newly emerging applications, like analyzing hyperlinks of the web graph and analyzing associations in a social network, that need to process massive graphs in a timely manner. Regarding the extremely large size of these graphs and knowledge they...
متن کاملOpen issues in Big Data Warehouse design
Data Warehouse and OLAP systems allow analyzing huge volumes of data represented according to the multidimensional model. In the era of Big Data, NoSQL systems have been proved to be an effective Business Intelligence solution. Some works recently study warehousing and OLAPing Big Data. (Un)Lucky these works exclusively investigate time performance related to the Volume and Velocity features of...
متن کاملPrivacy by design in big data
An overview of privacy enhancing technologies in the era of big data analytics FINAL 1.0 PUBLIC DECEMBER 2015 The European Union Agency for Network and Information Security (ENISA) is a centre of network and information security expertise for the EU, its member states, the private sector and Europe's citizens. ENISA works with these groups to develop advice and recommendations on good practice ...
متن کاملStatistics for Drug Development in Big Data Era: Challenges in Design, Analysis and Reproducibility
The statistical methods used for data-mining or signal detection of drug-adverse event combinations from large drug safety databases such as FDA’s Adverse Event Reporting System (FAERS), consisting of spontaneous reports on adverse events for post-market drugs are called passive surveillance methods. On the other hand, the statistical signal detection methods for longitudinal data, as the data ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chinese Science Bulletin
سال: 2015
ISSN: 0023-074X
DOI: 10.1360/n972014-01144